A Safer Alternative To Aspirin?
A study in China has shown that the antiplatelet* drug cilostazol is as effective as aspirin at preventing recurrent stroke, but causes less bleeding events. The results suggest cilostazol could be a safer alternative to aspirin post-stroke for Chinese patients, and warrant both phase III trials and studies in other populations. These are the conclusions of authors of an Article published early Online and in the June edition of The Lancet Neurology.
More: continued here
Filed under: Pain / Anesthetics on May 15th, 2008